David Preiss, Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), University of Oxford, UK, presents LENS trial results for fenofibrate in early diabetic retinopathy or maculopathy, and compares the data with those from hypothesis-generating CVD trials.
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
